您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Diltiazem
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Diltiazem
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Diltiazem图片
CAS NO:42399-41-7
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
地尔硫卓
产品介绍
Diltiazem 是一种口服 L 型钙通道 (L-type Ca2+channel) 阻滞剂。 Diltiazem 具有抗高血压和抗心律失常作用。Diltiazem 可用于心律失常、高血压和心绞痛的研究。
生物活性

Diltiazem is an orally activeL-type Ca2+channelblocker. Diltiazem shows antihypertensive and antiarrhythmic effects. Diltiazem can be used for the research of cardiac arrhythmia, hypertension, and angina pectoris[1][2][3].

IC50& Target

L-type Ca2+channel[1]

体外研究
(In Vitro)

Diltiazem (200 μM) elicits a use-dependent blockade that proceeded within a relatively small number of pulses[1].
Diltiazem reduces Ca2+influx by accelerating inactivation during action potentials, and that the use-dependent blockade is due to increases in the number of channels in a sustained closed state[1].

体内研究
(In Vivo)

Diltiazem (100 mg/kg; p.o.; for 4 weeks) prevents aortic aneurysm formation in a blood pressure-independent manner[3].
Diltiazem limits aortic aneurysm formation in mice by a blood pressure-independent anti-inflammatory effect on monocytic cells[3].
Diltiazem (2 mg/kg; i.v.) exhibits T1/2of 61.2 min, CLelof 3.2 mL/min in rats[4].

Animal Model:Male ApoE–/–mice, angiotensin II induced aneurysms[3]
Dosage:100 mg/kg
Administration:Oral administration, in drinking water, for 4 weeks
Result:Srongly reduced the vascular remodeling but also lowered the blood pressure.
Animal Model:Rat (200-250 g)[4]
Dosage:2 mg/kg (Pharmacokinetic Analysis)
Administration:Intravenous injection
Result:T1/2(61.2 min), CLel(3.2 mL/min)
Clinical Trial
分子量

414.52

Formula

C22H26N2O4S

CAS 号

42399-41-7

中文名称

地尔硫卓

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.